POSSIBLE IMPLICATION OF PEPTIDASE ACTIVITY IN DIFFERENT POTENCY OF ANGIOTENSIN-II AND ANGIOTENSIN-III FOR DISPLACING [I-125] ANGIOTENSIN-II BINDING IN PIG AORTA

被引:15
作者
FUJIMOTO, M
MIHARA, S
SHIGERI, Y
ITAZAKI, K
机构
[1] Shionogi Research Laboratories, Shionogi and Co., Ltd., Fukushima-ku, Osaka
关键词
ANGIOTENSIN RECEPTORS; ANGIOTENSIN-II; ANGIOTENSIN-III; SMOOTH MUSCLE CELLS; PROTEASE INHIBITORS;
D O I
10.1016/0014-2999(92)90036-4
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A single class of [I-125]angiotensin II ([I-125]AII) binding sites was found in porcine aortic smooth muscle membranes. Des-Asp1-AII (AIII) and des-Asp1-[Ile8]AII were 20 times less potent than All or [Sar1,Ile8]AII to displace [I-125]AII binding. In contrast, AII and AIII equipotently induced an increase in cytosolic free Ca2+ concentration in cultured porcine aortic smooth muscle cells. Des-Asp1-[Ile8]AII and [Sar1,Ile8]AII equipotently inhibited the increase induced by either AII or AIII. In order to explain this discrepancy, we studied [I-125]AIII binding. In the presence of amastatin or a potent inhibitor of aminopeptidase M, [I-125]AII binding remained stable for 90 min, but [I-125]AIII binding decreased gradually after the peak at 30 min. The decrease was completely blocked by the presence of amastatin and phenylmethylsulfonylfluoride. Consequently, AIII was as potent as AII to displace [I-125]AII binding in the presence of these two protease inhibitors. These results suggest that the lower potency of AIII to displace [I-125]AII binding is related primarily to AIII-specific degradation by proteases.
引用
收藏
页码:259 / 264
页数:6
相关论文
共 26 条
[1]  
AHMAD S, 1990, J PHARMACOL EXP THER, V252, P643
[2]   A DOSE-RESPONSE COMPARISON OF THE ACTIONS OF ANGIOTENSIN-II AND ANGIOTENSIN-III IN SHEEP [J].
BLAIRWEST, JR ;
COGHLAN, JP ;
DENTON, DA ;
FEI, DTW ;
HARDY, KJ ;
SCOGGINS, BA ;
WRIGHT, RD .
JOURNAL OF ENDOCRINOLOGY, 1980, 87 (03) :409-417
[3]   INTRACELLULAR PROTEASES [J].
BOND, JS ;
BUTLER, PE .
ANNUAL REVIEW OF BIOCHEMISTRY, 1987, 56 :333-364
[4]   ANGIOTENSIN-II-INDUCED AND ANGIOTENSIN-III-INDUCED ALDOSTERONE RELEASE INVIVO IN RAT [J].
CAMPBELL, WB ;
BROOKS, SN ;
PETTINGER, WA .
SCIENCE, 1974, 184 (4140) :994-996
[5]  
CHANG RSL, 1990, MOL PHARMACOL, V37, P347
[6]  
CHIU AT, 1990, J PHARMACOL EXP THER, V252, P711
[7]   IDENTIFICATION OF ANGIOTENSIN-II RECEPTOR SUBTYPES [J].
CHIU, AT ;
HERBLIN, WF ;
MCCALL, DE ;
ARDECKY, RJ ;
CARINI, DJ ;
DUNCIA, JV ;
PEASE, LJ ;
WONG, PC ;
WEXLER, RR ;
JOHNSON, AL ;
TIMMERMANS, PBMWM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 165 (01) :196-203
[8]   ANGIOTENSIN-III - (DES-ASPARTIC ACID)-ANGIOTENSIN-II - EVIDENCE AND SPECULATION FOR ITS ROLE AS AN IMPORTANT AGONIST IN RENINANGIOTENSIN SYSTEM [J].
GOODFRIEND, TL ;
PEACH, MJ .
CIRCULATION RESEARCH, 1975, 36 (06) :38-48
[9]   PREPARATION OF 131I-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY [J].
GREENWOOD, FC ;
HUNTER, WM .
BIOCHEMICAL JOURNAL, 1963, 89 (01) :114-&
[10]  
MCCONAHEY P, 1980, IMMUNOCHEMICAL TEC A, V70, P210